Notable companies
The most notable companies in this group are Moderna (NASDAQ:MRNA), Exact Sciences Corp (NASDAQ:EXAS).
Industry description
The investment seeks capital appreciation.
The portfolio managers seeks to meet its investment objective by investing primarily in common stocks and other equity securities of companies that the portfolio managers believe have the potential to bring substantial improvements in human health and healthcare systems. Under normal circumstances, the fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities of companies engaged in or supporting innovation in one or more healthcare or healthcare-related industries. The fund is non-diversified.
Market Cap
The average market capitalization across the Baillie Gifford Health Inn Eq Instl MF is 24.17B. The market cap for tickers in the group ranges from 4.42B to 53.47B. DXCM holds the highest valuation in this group at 53.47B. The lowest valued company is TXG at 4.42B.
Volume
The average weekly volume growth across all stocks in the Baillie Gifford Health Inn Eq Instl MF was 2%. For the same stocks of the MF, the average monthly volume growth was -62% and the average quarterly volume growth was 30%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 63
P/E Growth Rating: 83
Price Growth Rating: 56
SMR Rating: 79
Profit Risk Rating: 71
Seasonality Score: -30 (-100 ... +100)